United States newsroom

If isavuconazole is approved for invasive candidiasis, QIDP status provides a five-year extension of market exclusivity. NORTHBROOK, Ill., July 16, 2014 /PRNewswire/ -- Astellas today announced...

NORTHBROOK, Ill., July 9, 2014 /PRNewswire/ -- Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for...

NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas announces the appointment of Marty Golden, J.D. as vice president, Government Affairs, which is effective on July 1, 2014. In this role,...

NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas has named Tatjana Dragovic, J.D., vice president and regional compliance officer for its Americas region. In this role, she will oversee...

- Uhlendorf is leaving his current position as Vice President, Communications and Public Affairs at PhRMA - NORTHBROOK, Ill., June 24, 2014 /PRNewswire/ -- Astellas announces the appointment of...

Special Patient-Focused Event Kicks Off Astellas' Fifth Annual Changing Tomorrow Day Initiative KISSIMMEE, Fla., June 11, 2014 /PRNewswire/ -- About 1,400 Astellas Pharma employees will be...

-Study appears in June 1 online edition- NORTHBROOK, Ill. and SAN FRANCISCO, JUNE 1, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:...

NORTHBROOK, Ill., May 14, 2014 /PRNewswire/ -- Astellas reported today that the efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European...

Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of...

NORTHBROOK, Ill., May 2, 2014 /PRNewswire/ -- Astellas announces the promotion of Bernhardt Zeiher, M.D. ("Bernie") to the position of executive vice president, Global Development and the...